Looking for a category-level comparison instead of a single model? Start with IOL Options to understand the broad categories — monofocal, enhanced monofocal, EDOF, and full-range/trifocal — before drilling into individual models here.
IOL Model Reviews
Model-by-model reviews built from FDA records and peer-reviewed studies. I look for the result that changes a decision: a real benefit, a target the study did not meet, a symptom rate or a gap the brochure does not answer.

Reviewed lenses
Tecnis Eyhance Review
An enhanced monofocal lens designed to add intermediate range to a standard monofocal's clarity.
enVista Aspire IOL Review
A sensible enhanced-monofocal design, but its headline gains rely on internal and model-eye data; the main clinical study has 29 eyes and no control.
TECNIS Symfony Review
A diffractive EDOF lens reviewed from its FDA trial and randomized comparative evidence — including intermediate range, spectacle use and night symptoms.
TECNIS PureSee Review
A newer non-diffractive EDOF lens from J&J — reviewed using its FDA registration study data, with source-cited charts.
TECNIS Synergy Review
J&J's diffractive extended-range lens — strong spectacle independence alongside a meaningfully higher halo/glare rate, per its FDA data.
Alcon PanOptix Review
A widely used trifocal IOL aiming for distance, intermediate, and near vision without glasses — reviewed from its FDA registration data.
Alcon Vivity Review
A non-diffractive EDOF lens positioned between enhanced monofocal and full presbyopia-correcting designs — including a trial target it didn't meet.
TECNIS Odyssey Review
J&J's newest full-range IOL — reviewed from independent peer-reviewed studies, since no FDA SSED is yet published for this lens.
Monofocal lens reviews
Model-by-model looks at standard single-focus lenses, the most established IOL category.
New articles
All articles →
PureSee vs Eyhance: which lens is better for computer work and reading?
PureSee or Eyhance for computer work and reading? What direct patient studies found, where glasses may still be needed, and what to ask your surgeon.

enVista Aspire: what the new 141-eye study tells us—and what it does not
A closer look at Aspire outcomes in 141 eyes: the people behind “100%”, missing comparison groups, testing distances and the current safety wording.

TECNIS Odyssey: good near-to-far vision—but what do the halo numbers really mean?
Odyssey clinical studies reviewed: why noticing halos differs from bother, what contrast tests measured and where comparisons with other IOLs remain limited.